| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 5.71e-06 | 4 | 20 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.32e-04 | 188 | 20 | 3 | GO:0005201 | |
| GeneOntologyCellularComponent | Golgi lumen | 8.91e-10 | 109 | 21 | 6 | GO:0005796 | |
| Domain | SEA_dom | 3.57e-11 | 23 | 21 | 5 | IPR000082 | |
| Domain | SEA | 3.57e-11 | 23 | 21 | 5 | PS50024 | |
| Domain | SEA | 1.17e-09 | 14 | 21 | 4 | SM00200 | |
| Domain | SEA | 8.53e-09 | 22 | 21 | 4 | PF01390 | |
| Domain | - | 1.25e-04 | 15 | 21 | 2 | 3.30.70.960 | |
| Domain | EGF_1 | 1.69e-04 | 255 | 21 | 4 | PS00022 | |
| Domain | EGF-like_CS | 1.85e-04 | 261 | 21 | 4 | IPR013032 | |
| Domain | EGF_2 | 1.96e-04 | 265 | 21 | 4 | PS01186 | |
| Domain | EGF | 2.21e-03 | 235 | 21 | 3 | SM00181 | |
| Domain | EGF_3 | 2.21e-03 | 235 | 21 | 3 | PS50026 | |
| Domain | EGF-like_dom | 2.61e-03 | 249 | 21 | 3 | IPR000742 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 4.09e-12 | 16 | 16 | 5 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 5.78e-12 | 17 | 16 | 5 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.13e-11 | 23 | 16 | 5 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 6.11e-11 | 26 | 16 | 5 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 5.87e-09 | 62 | 16 | 5 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 9.43e-09 | 68 | 16 | 5 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.13e-07 | 111 | 16 | 5 | M27416 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 3.60e-07 | 140 | 16 | 5 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.00e-07 | 143 | 16 | 5 | M27275 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.58e-06 | 21 | 16 | 3 | MM15706 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 6.27e-06 | 250 | 16 | 5 | M27554 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 3.95e-05 | 60 | 16 | 3 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.34e-04 | 109 | 16 | 3 | MM15164 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 1.03e-03 | 1128 | 16 | 6 | M1036 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 4.09e-13 | 18 | 21 | 5 | 18834073 | |
| Pubmed | 1.90e-10 | 3 | 21 | 3 | 10512748 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 9334251 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 12958310 | ||
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 3.47e-07 | 2 | 21 | 2 | 2393399 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 11289722 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 3.47e-07 | 2 | 21 | 2 | 10973822 | |
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 3.47e-07 | 2 | 21 | 2 | 10405327 | |
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 1.04e-06 | 3 | 21 | 2 | 18163520 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 26770020 | ||
| Pubmed | 3.73e-06 | 407 | 21 | 5 | 12693553 | ||
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 19110483 | ||
| Pubmed | Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway. | 1.25e-05 | 9 | 21 | 2 | 28169360 | |
| Pubmed | DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2. | 3.15e-05 | 14 | 21 | 2 | 28087714 | |
| Pubmed | 5.90e-05 | 19 | 21 | 2 | 35340430 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.34e-04 | 861 | 21 | 5 | 36931259 | |
| Cytoband | 7q22 | 6.89e-07 | 38 | 21 | 3 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 1.34e-04 | 219 | 21 | 3 | chr7q22 | |
| GeneFamily | CD molecules|Mucins | 8.90e-15 | 21 | 16 | 6 | 648 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.55e-07 | 170 | 20 | 5 | M5880 | |
| ToppCell | 10x5'-GI_small-bowel|World / Manually curated celltypes from each tissue | 1.51e-06 | 193 | 20 | 4 | cd89dfe53a114078f06343049685883c8e26508f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.65e-05 | 131 | 20 | 3 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.47e-05 | 167 | 20 | 3 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.72e-05 | 179 | 20 | 3 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.83e-05 | 180 | 20 | 3 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.83e-05 | 180 | 20 | 3 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 7.17e-05 | 183 | 20 | 3 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 7.29e-05 | 184 | 20 | 3 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.29e-05 | 184 | 20 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 8.40e-05 | 193 | 20 | 3 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | IIH-mono3|IIH / Condition, Cell_class and T cell subcluster | 8.66e-05 | 195 | 20 | 3 | c6dd5af582d257be64b718e30f60220c1bf1738a | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 8.66e-05 | 195 | 20 | 3 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | IIH-mono3-|IIH / Condition, Cell_class and T cell subcluster | 8.66e-05 | 195 | 20 | 3 | 28a858b04a7b413916c07a8d880f5ea02e985461 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 8.92e-05 | 197 | 20 | 3 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 8.92e-05 | 197 | 20 | 3 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.06e-05 | 198 | 20 | 3 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.06e-05 | 198 | 20 | 3 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.06e-05 | 198 | 20 | 3 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.06e-05 | 198 | 20 | 3 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.33e-05 | 200 | 20 | 3 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| Drug | rioprostil | 3.30e-06 | 32 | 21 | 3 | CID005311413 | |
| Drug | cellobiitol | 5.15e-06 | 37 | 21 | 3 | CID000003871 | |
| Drug | inulin | 6.17e-06 | 133 | 21 | 4 | CID000024763 | |
| Drug | Gastrin tetrapeptide | 1.29e-05 | 50 | 21 | 3 | CID000005415 | |
| Drug | mucic acid | 7.06e-05 | 88 | 21 | 3 | CID000000607 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.26e-05 | 64 | 21 | 3 | DOID:4947 (is_marker_for) | |
| Disease | cholesteryl ester 14:0 measurement | 1.68e-04 | 27 | 21 | 2 | EFO_0010340 | |
| Disease | serum alanine aminotransferase measurement | 3.01e-04 | 869 | 21 | 5 | EFO_0004735 | |
| Disease | heart rate response to exercise | 4.28e-04 | 43 | 21 | 2 | EFO_0009184 | |
| Disease | plasminogen activator inhibitor 1 measurement | 6.75e-04 | 54 | 21 | 2 | EFO_0004792 | |
| Disease | HOMA-B | 7.00e-04 | 55 | 21 | 2 | EFO_0004469 | |
| Disease | pancreatic cancer (is_marker_for) | 2.33e-03 | 101 | 21 | 2 | DOID:1793 (is_marker_for) | |
| Disease | apolipoprotein A 1 measurement | 2.74e-03 | 848 | 21 | 4 | EFO_0004614 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 2.76e-03 | 110 | 21 | 2 | EFO_0803335 | |
| Disease | intelligence, self reported educational attainment | 3.12e-03 | 117 | 21 | 2 | EFO_0004337, EFO_0004784 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITMTTTSVSSWPYSS | 6 | Q9UPC5 | |
| QTSESMTPTATSETY | 51 | Q8WV93 | |
| STMEDTSVSTSTPGF | 8091 | Q8WXI7 | |
| EMESSVYQPTSSSST | 14306 | Q8WXI7 | |
| TGPMTATSFQTTTTY | 1981 | Q6W4X9 | |
| MGEFPSSSESTFTST | 461 | O95279 | |
| TSTYSMTTTEKGTSA | 171 | Q02505 | |
| ASSMTTSETTYPNSP | 701 | Q02505 | |
| YPTTMTETSSTATSL | 1481 | Q02505 | |
| STPSPTTTMSFTTFT | 1696 | Q02505 | |
| PSYQSMTSLHTSSES | 1361 | Q8IVL0 | |
| AGSTYSVLSTMPSDS | 101 | Q8TDM6 | |
| STAMGSSVPYSTAKT | 1136 | P35658 | |
| TSTTYSSSARFMPGT | 181 | Q0D2I5 | |
| STMTPGQITYTATST | 131 | Q9H1M3 | |
| SVHSPSTSMATSSQY | 21 | O14519 | |
| SGQSSEVSTPSSLYM | 436 | Q92622 | |
| STTAEGTSMPTSTYS | 611 | Q685J3 | |
| GTSMPTSTYSERGTT | 616 | Q685J3 | |
| TSTYSERGTTITSMS | 621 | Q685J3 | |
| TTAEGTSMPTSTYTE | 671 | Q685J3 | |
| TSMQTSTYSEGSTPL | 1561 | Q685J3 | |
| TADDTSMPTSTYSEG | 2381 | Q685J3 | |
| ATSAEGTSMPTSTYS | 2556 | Q685J3 | |
| DGTSMPTSTYSEGST | 3326 | Q685J3 | |
| TTVTFGSMDSSTSTL | 511 | Q9H195 | |
| MSSTSTRSGSSDSSY | 26 | Q9BW04 | |
| FSSMTSDSDTTSPTG | 396 | P42331 | |
| ESTDSGLSMSSYSVP | 396 | P46937 | |
| SSEYSSSSSSPMGVQ | 416 | Q8WYQ9 | |
| SSGYSSPTTSEMSIK | 2246 | Q96AY4 | |
| ESTTYHSSPGSTQTM | 4551 | Q9UKN1 | |
| SSSSSFSVSPTYSMT | 481 | O15146 |